Highlights Syncona Limited

Equities

Market Closed - London S.E. Other stock markets 11:35:14 2024-04-26 am EDT			5-day change	1st Jan Change
128.4 ^GBX	+1.10%		+5.77%	+4.05%

Apr. 11	Syncona agrees to sell stake in investee company for GBP7.4 million	AN
Apr. 11	Syncona to Sell Stake in Portfolio Company to Century Therapeutics	MT

Syncona agrees to sell stake in investee company for GBP7.4 million	Apr. 11	AN
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	Apr. 11	MT
Syncona notes investee Achilles's annual loss narrows	Apr. 04	AN
Syncona portfolio company Autolus posts widened loss for 2023	Mar. 14	AN
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	Feb. 20	MT
Freeline shareholders approve Syncona acquisition	Feb. 12	AN
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	Feb. 12	MT
Syncona portfolio strengthens in third quarter thanks to Autolus	Feb. 08	AN
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.	Feb. 08	CI
Syncona notes FDA acceptance of Autolus's BLA for obe-cel	Jan. 22	AN
Syncona says Freeline trial for Gaucher disease treatment positive	Jan. 19	AN
Syncona agrees to buyout deal with Freeline Therapeutics	Nov. 22	AN
Syncona to Take Over Freeline Therapeutics	Nov. 22	MT
Freeline Therapeutics to be Acquired by Syncona for $28.3 Million	Nov. 22	MT
Syncona reports declining asset value as investment head steps down	Nov. 16	AN
Syncona Swings to Fiscal H1 Loss; Invest Income Falls	Nov. 16	MT
Earnings Flash (SYNC.L) SYNCONA Posts Fiscal H1 Loss GBX-8.01	Nov. 16	MT
Syncona Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 15	CI
Syncona notes investee company's quarterly loss	Nov. 14	AN
Syncona Submits Takeover Bid for Freeline Therapeutics	23-10-18	MT

No results for this search